Wnt1 inhibits vascular smooth muscle cell calcification by promoting ANKH expression

Wnt signaling plays a critical role in vascular calcification (VC). Wnt factors induce different physiological and pathological effects on cardiovascular functions. Wnt1, a ligand of Wnt/β-catenin signaling, promotes pro-angiogenesis and reduces myocardial infarction. The role of Wnt1 on VC in chron...

Full description

Saved in:
Bibliographic Details
Published inJournal of molecular and cellular cardiology Vol. 135; pp. 10 - 21
Main Authors Chen, Beidong, Zhao, Yang, Han, Duanyang, Zhao, Ban, Mao, Yonghui, Cui, Zhong-Kai, Chu, Yun-Chin, Feng, Lu, Yin, Sen, Wang, Cun-Yu, Wang, Xian, Xu, Ming-Jiang, Zhao, Gexin
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.10.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Wnt signaling plays a critical role in vascular calcification (VC). Wnt factors induce different physiological and pathological effects on cardiovascular functions. Wnt1, a ligand of Wnt/β-catenin signaling, promotes pro-angiogenesis and reduces myocardial infarction. The role of Wnt1 on VC in chronic kidney disease (CKD) is not fully understood. We used human vascular smooth muscle cells (VSMCs) and a rat model of chronic renal failure (CRF), and observed a native protective mechanism by which VC is reduced via the activation of Wnt1 and its transcriptional target ANKH inorganic pyrophosphate transport regulator (ANKH) gene. ANKH is an essential calcification inhibitor that effluxes inorganic pyrophosphate (PPi) from VSMCs to play an inhibitory role in VC. Vascular ANKH and plasma PPi were significantly downregulated in the rat model of CRF. The knockdown or inhibition of ANKH reversed the effect of Wnt1 on VC in VSMCs. Clinical analysis revealed low plasma levels of Wnt1 and PPi were associated with CKD in patients. Applying a Wnt/β-catenin signaling agonist can alleviate the progression of VC. This work reveals the ANKH regulation of Wnt1 in VSMCs is essential for blocking VC. Our findings may contribute to the development of medications that target Wnt signaling and/or ANKH to inhibit VC. •Novel mechanism of Wnt1 protects against vascular calcification.•ANKH, a vascular calcification inhibitor, is a target gene of Wnt1/β-catenin signal.•Agonist of Wnt/β-catenin signal is a potential medicine for vascular calcification.
AbstractList Wnt signaling plays a critical role in vascular calcification (VC). Wnt factors induce different physiological and pathological effects on cardiovascular functions. Wnt1, a ligand of Wnt/β-catenin signaling, promotes pro-angiogenesis and reduces myocardial infarction. The role of Wnt1 on VC in chronic kidney disease (CKD) is not fully understood. We used human vascular smooth muscle cells (VSMCs) and a rat model of chronic renal failure (CRF), and observed a native protective mechanism by which VC is reduced via the activation of Wnt1 and its transcriptional target ANKH inorganic pyrophosphate transport regulator (ANKH) gene. ANKH is an essential calcification inhibitor that effluxes inorganic pyrophosphate (PPi) from VSMCs to play an inhibitory role in VC. Vascular ANKH and plasma PPi were significantly downregulated in the rat model of CRF. The knockdown or inhibition of ANKH reversed the effect of Wnt1 on VC in VSMCs. Clinical analysis revealed low plasma levels of Wnt1 and PPi were associated with CKD in patients. Applying a Wnt/β-catenin signaling agonist can alleviate the progression of VC. This work reveals the ANKH regulation of Wnt1 in VSMCs is essential for blocking VC. Our findings may contribute to the development of medications that target Wnt signaling and/or ANKH to inhibit VC. •Novel mechanism of Wnt1 protects against vascular calcification.•ANKH, a vascular calcification inhibitor, is a target gene of Wnt1/β-catenin signal.•Agonist of Wnt/β-catenin signal is a potential medicine for vascular calcification.
Wnt signaling plays a critical role in vascular calcification (VC). Wnt factors induce different physiological and pathological effects on cardiovascular functions. Wnt1, a ligand of Wnt/β-catenin signaling, promotes pro-angiogenesis and reduces myocardial infarction. The role of Wnt1 on VC in chronic kidney disease (CKD) is not fully understood. We used human vascular smooth muscle cells (VSMCs) and a rat model of chronic renal failure (CRF), and observed a native protective mechanism by which VC is reduced via the activation of Wnt1 and its transcriptional target ANKH inorganic pyrophosphate transport regulator (ANKH) gene. ANKH is an essential calcification inhibitor that effluxes inorganic pyrophosphate (PPi) from VSMCs to play an inhibitory role in VC. Vascular ANKH and plasma PPi were significantly downregulated in the rat model of CRF. The knockdown or inhibition of ANKH reversed the effect of Wnt1 on VC in VSMCs. Clinical analysis revealed low plasma levels of Wnt1 and PPi were associated with CKD in patients. Applying a Wnt/β-catenin signaling agonist can alleviate the progression of VC. This work reveals the ANKH regulation of Wnt1 in VSMCs is essential for blocking VC. Our findings may contribute to the development of medications that target Wnt signaling and/or ANKH to inhibit VC.
Wnt signaling plays a critical role in vascular calcification (VC). Wnt factors induce different physiological and pathological effects on cardiovascular functions. Wnt1, a ligand of Wnt/β-catenin signaling, promotes pro-angiogenesis and reduces myocardial infarction. The role of Wnt1 on VC in chronic kidney disease (CKD) is not fully understood.AIMSWnt signaling plays a critical role in vascular calcification (VC). Wnt factors induce different physiological and pathological effects on cardiovascular functions. Wnt1, a ligand of Wnt/β-catenin signaling, promotes pro-angiogenesis and reduces myocardial infarction. The role of Wnt1 on VC in chronic kidney disease (CKD) is not fully understood.We used human vascular smooth muscle cells (VSMCs) and a rat model of chronic renal failure (CRF), and observed a native protective mechanism by which VC is reduced via the activation of Wnt1 and its transcriptional target ANKH inorganic pyrophosphate transport regulator (ANKH) gene. ANKH is an essential calcification inhibitor that effluxes inorganic pyrophosphate (PPi) from VSMCs to play an inhibitory role in VC. Vascular ANKH and plasma PPi were significantly downregulated in the rat model of CRF. The knockdown or inhibition of ANKH reversed the effect of Wnt1 on VC in VSMCs. Clinical analysis revealed low plasma levels of Wnt1 and PPi were associated with CKD in patients. Applying a Wnt/β-catenin signaling agonist can alleviate the progression of VC.METHODS AND RESULTSWe used human vascular smooth muscle cells (VSMCs) and a rat model of chronic renal failure (CRF), and observed a native protective mechanism by which VC is reduced via the activation of Wnt1 and its transcriptional target ANKH inorganic pyrophosphate transport regulator (ANKH) gene. ANKH is an essential calcification inhibitor that effluxes inorganic pyrophosphate (PPi) from VSMCs to play an inhibitory role in VC. Vascular ANKH and plasma PPi were significantly downregulated in the rat model of CRF. The knockdown or inhibition of ANKH reversed the effect of Wnt1 on VC in VSMCs. Clinical analysis revealed low plasma levels of Wnt1 and PPi were associated with CKD in patients. Applying a Wnt/β-catenin signaling agonist can alleviate the progression of VC.This work reveals the ANKH regulation of Wnt1 in VSMCs is essential for blocking VC. Our findings may contribute to the development of medications that target Wnt signaling and/or ANKH to inhibit VC.CONCLUSIONThis work reveals the ANKH regulation of Wnt1 in VSMCs is essential for blocking VC. Our findings may contribute to the development of medications that target Wnt signaling and/or ANKH to inhibit VC.
Author Xu, Ming-Jiang
Feng, Lu
Yin, Sen
Cui, Zhong-Kai
Chu, Yun-Chin
Zhao, Ban
Mao, Yonghui
Wang, Cun-Yu
Zhao, Yang
Han, Duanyang
Chen, Beidong
Wang, Xian
Zhao, Gexin
Author_xml – sequence: 1
  givenname: Beidong
  orcidid: 0000-0002-0561-7873
  surname: Chen
  fullname: Chen, Beidong
  organization: MOH Key Laboratory of Geriatrics, Beijing Hospital, National Center of Gerontology, Beijing, China
– sequence: 2
  givenname: Yang
  surname: Zhao
  fullname: Zhao, Yang
  organization: Department of Laboratory Medicine, Peking University Third Hospital, Beijing, China
– sequence: 3
  givenname: Duanyang
  surname: Han
  fullname: Han, Duanyang
  organization: Shenzhen Key Laboratory of Spine Surgery, Department of Spine Surgery, Peking University Shenzhen Hospital, Shenzhen, China
– sequence: 4
  givenname: Ban
  surname: Zhao
  fullname: Zhao, Ban
  organization: Department of Nephrology, Beijing Hospital, Beijing, China
– sequence: 5
  givenname: Yonghui
  surname: Mao
  fullname: Mao, Yonghui
  organization: Department of Nephrology, Beijing Hospital, Beijing, China
– sequence: 6
  givenname: Zhong-Kai
  orcidid: 0000-0003-3112-9379
  surname: Cui
  fullname: Cui, Zhong-Kai
  organization: Department of Cell Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
– sequence: 7
  givenname: Yun-Chin
  surname: Chu
  fullname: Chu, Yun-Chin
  organization: Department of Statistics, North Carolina State University, USA
– sequence: 8
  givenname: Lu
  surname: Feng
  fullname: Feng, Lu
  organization: MOH Key Laboratory of Geriatrics, Beijing Hospital, National Center of Gerontology, Beijing, China
– sequence: 9
  givenname: Sen
  surname: Yin
  fullname: Yin, Sen
  organization: MOH Key Laboratory of Geriatrics, Beijing Hospital, National Center of Gerontology, Beijing, China
– sequence: 10
  givenname: Cun-Yu
  surname: Wang
  fullname: Wang, Cun-Yu
  organization: School of Dentistry, University of California, Los Angeles, USA
– sequence: 11
  givenname: Xian
  surname: Wang
  fullname: Wang, Xian
  organization: Department of Physiology and Pathophysiology, School of Basic Medical Science, Peking University Health Science Center, Beijing, China
– sequence: 12
  givenname: Ming-Jiang
  surname: Xu
  fullname: Xu, Ming-Jiang
  email: mingjiangxu@bjmu.edu.cn
  organization: Department of Physiology and Pathophysiology, School of Basic Medical Science, Peking University Health Science Center, Beijing, China
– sequence: 13
  givenname: Gexin
  orcidid: 0000-0003-2278-3432
  surname: Zhao
  fullname: Zhao, Gexin
  email: zhaogexin@ucla.edu
  organization: Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31356809$$D View this record in MEDLINE/PubMed
BookMark eNqFkU1v1DAQhi3Uim4LvwAJ-cglYWwncSLEoaroh6jgUsTRcpwJ9ZLYi-1U7L-vt9teemhPI3neZzTz-JgcOO-QkA8MSgas-bwut-vZmJID60qQJUD7hqwYdHXR1m11QFYAnBe85e0ROY5xDQBdJcRbciSYqJsWuhW5-e0So9bd2t6mSO90NMukA42z9-mWzks0E1KD00SNnowdrdHJekf7Ld0EP_tk3R96-uP7JcX_m4Ax5uY7cjjqKeL7x3pCfp1_uzm7LK5_XlydnV4XppIyFU2vK-xYxSTrmRmaRnKuORMDZ1Ulse5HwXnLqnYUve4HyM9NnZM1Mq0bBHFCPu3n5k3-LRiTmm3c7aod-iUqzhsJjEshc_TjY3TpZxzUJthZh616MpED3T5ggo8x4KiMTQ-npqDtpBionXW1Vg_W1c66Aqmy9cyKZ-zT-Jepr3sKs6I7i0FFY9EZHGxAk9Tg7Sv8l2e8mazL_zP9xe2r9D2WnbA8
CitedBy_id crossref_primary_10_1038_s41598_020_77732_5
crossref_primary_10_3389_fcell_2020_586831
crossref_primary_10_1016_j_bone_2020_115243
crossref_primary_10_1016_j_lfs_2023_122309
crossref_primary_10_12677_ACM_2022_132169
crossref_primary_10_1016_j_acthis_2020_151551
crossref_primary_10_1080_0886022X_2022_2072337
crossref_primary_10_14336_AD_2021_1024
crossref_primary_10_2147_VHRM_S242685
crossref_primary_10_1016_j_bone_2020_115656
crossref_primary_10_3389_fgene_2022_838220
crossref_primary_10_1016_j_jacc_2023_01_044
crossref_primary_10_2139_ssrn_3894903
crossref_primary_10_2174_1567202619666220316115425
crossref_primary_10_1080_0886022X_2022_2114370
crossref_primary_10_1016_j_bone_2022_116525
Cites_doi 10.1038/ki.2012.40
10.1038/ki.2015.194
10.5414/CN108547
10.1093/ckj/sfv077
10.1161/01.RES.0000216409.20863.e7
10.1038/ncomms10006
10.1359/jbmr.070714
10.1161/ATVBAHA.107.153668
10.1681/ASN.2004030203
10.1186/1471-2369-14-219
10.1186/s12858-016-0066-9
10.1161/01.ATV.0000154774.71187.f0
10.1074/jbc.M109.050534
10.1681/ASN.2013080818
10.1038/ki.2008.644
10.1111/j.1525-139X.2007.00300.x
10.1152/ajpcell.00419.2009
10.1111/j.1474-9726.2010.00661.x
10.1093/ndt/gfv111
10.1172/JCI24140
10.1126/science.1136370
10.2337/db14-0326
10.1096/fj.10-172981
10.1371/journal.pone.0019595
10.1093/ndt/gfv081
10.1016/j.bone.2009.09.006
10.1016/S0140-6736(01)06299-7
10.1161/ATVBAHA.110.204834
10.1126/science.289.5477.265
10.1093/ndt/gfg414
10.1016/j.atherosclerosis.2012.02.017
10.1016/j.devcel.2009.06.016
10.1681/ASN.2004080694
10.1093/ndt/gfp362
10.1152/ajpheart.01173.2003
10.1056/NEJM200005183422003
10.1038/nrcardio.2010.115
10.1161/CIRCRESAHA.117.306712
10.1006/dbio.1997.8552
10.1038/386078a0
10.1016/j.cell.2006.10.018
10.1016/j.regpep.2005.02.017
ContentType Journal Article
Copyright 2019 Elsevier Ltd
Copyright © 2019 Elsevier Ltd. All rights reserved.
Copyright_xml – notice: 2019 Elsevier Ltd
– notice: Copyright © 2019 Elsevier Ltd. All rights reserved.
DBID AAYXX
CITATION
NPM
7X8
DOI 10.1016/j.yjmcc.2019.07.008
DatabaseName CrossRef
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList

PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1095-8584
EndPage 21
ExternalDocumentID 31356809
10_1016_j_yjmcc_2019_07_008
S0022282818311970
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
29L
3O-
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8P~
9JM
AABNK
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABFRF
ABGSF
ABJNI
ABLJU
ABMAC
ABMZM
ABUDA
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADFGL
ADMUD
ADNMO
ADUVX
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGRDE
AGUBO
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CAG
COF
CS3
DM4
DU5
EBS
EFBJH
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEB
HLW
HMK
HMO
HVGLF
HZ~
IHE
J1W
K-O
KOM
L7B
LX2
M29
M41
MO0
N9A
O-L
O9-
OAUVE
OA~
OL0
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SAE
SBG
SCC
SDF
SDG
SDP
SEL
SES
SEW
SPCBC
SSH
SSZ
T5K
WUQ
X7M
XPP
Z5R
ZGI
ZMT
ZU3
~G-
AACTN
AAIAV
ABLVK
ABYKQ
AEHWI
AFKWA
AHPSJ
AJBFU
AJOXV
AMFUW
DOVZS
EFLBG
LCYCR
RIG
SSU
AAYXX
AFCTW
AGRNS
CITATION
NPM
7X8
ID FETCH-LOGICAL-c477t-6ba4e914171b1cd66722a213d21447e5bf3228148f3babd021465b1c5e1aa6e03
IEDL.DBID .~1
ISSN 0022-2828
1095-8584
IngestDate Mon Jul 21 09:23:39 EDT 2025
Wed Feb 19 02:30:17 EST 2025
Thu Apr 24 22:56:16 EDT 2025
Tue Jul 01 04:05:28 EDT 2025
Fri Feb 23 02:29:12 EST 2024
Tue Aug 26 17:11:59 EDT 2025
IsPeerReviewed true
IsScholarly true
Keywords Vascular calcification
Chronic kidney disease
ANKH
Wnt1
Vascular smooth muscle cells
Language English
License Copyright © 2019 Elsevier Ltd. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c477t-6ba4e914171b1cd66722a213d21447e5bf3228148f3babd021465b1c5e1aa6e03
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-0561-7873
0000-0003-3112-9379
0000-0003-2278-3432
PMID 31356809
PQID 2267012737
PQPubID 23479
PageCount 12
ParticipantIDs proquest_miscellaneous_2267012737
pubmed_primary_31356809
crossref_citationtrail_10_1016_j_yjmcc_2019_07_008
crossref_primary_10_1016_j_yjmcc_2019_07_008
elsevier_sciencedirect_doi_10_1016_j_yjmcc_2019_07_008
elsevier_clinicalkey_doi_10_1016_j_yjmcc_2019_07_008
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate October 2019
2019-10-00
20191001
PublicationDateYYYYMMDD 2019-10-01
PublicationDate_xml – month: 10
  year: 2019
  text: October 2019
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Journal of molecular and cellular cardiology
PublicationTitleAlternate J Mol Cell Cardiol
PublicationYear 2019
Publisher Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
References O'Neill, Sigrist, McIntyre (bb0205) 2010 Jan; 25
Narisawa, Harmey, Yadav, O'Neill, Hoylaerts, Millan (bb0095) 2007 Nov; 22
Zhao, Xu, Zhao, Dai, Kong, Wilson (bb0105) 2012 Jul; 82
Luo, Ducy, McKee, Pinero, Loyer, Behringer (bb0160) 1997 Mar 6; 386
Qureshi, Olauson, Witasp, Haarhaus, Brandenburg, Wernerson (bb0050) 2015 Dec; 88
Cailotto, Sebillaud, Netter, Jouzeau, Bianchi (bb0165) 2010 Apr 2; 285
Shao, Cheng, Pingsterhaus, Charlton-Kachigian, Loewy, Towler (bb0030) 2005 May; 115
Cheng, Behrmann, Shao, Ramachandran, Krchma, Bello Arredondo (bb0035) 2014 Dec; 63
Fang, Ginsberg, Seifert, Agapova, Sugatani, Register (bb0045) 2014 Aug; 25
Kirkpantur, Balci, Turkvatan, Afsar (bb0055) 2015 Dec; 8
Zhu, Mackenzie, Millan, Farquharson, MacRae (bb0130) 2011; 6
Mani, Radhakrishnan, Wang, Mani, Nelson-Williams, Carew (bb0075) 2007 Mar 2; 315
Sage, Tintut, Demer (bb0080) 2010 Sep; 7
Giachelli (bb0125) 2009 May; 75
Foley, Murray, Li, Herzog, McBean, Eggers (bb0005) 2005 Feb; 16
Wang, Adhikari, Li, Hall (bb0090) 2004 Dec; 287
Fukuda, Sano, Kazetani, Yamamoto, Iwata, Matsui (bb0145) 2016 May 20; 17
Al-Aly, Shao, Lai, Huang, Cai, Behrmann (bb0180) 2007 Dec; 27
London, Guerin, Marchais, Metivier, Pannier, Adda (bb0020) 2003 Sep; 18
Johnson, Polewski, van Etten, Terkeltaub (bb0100) 2005 Apr; 25
Hruska, Saab, Mathew, Lund (bb0120) 2007 Jul-Aug; 20
Neven, Persy, Dauwe, De Schutter, De Broe, D'Haese (bb0040) 2010 Sep; 30
Lomashvili, Khawandi, O'Neill (bb0170) 2005 Aug; 16
Marchand, Atassi, Gaaya, Leprince, Le Feuvre, Soubrier (bb0190) 2011 Apr; 10
Goodman, Goldin, Kuizon, Yoon, Gales, Sider (bb0010) 2000 May 18; 342
Goliasch, Wiesbauer, Kastl, Katsaros, Blessberger, Maurer (bb0070) 2012 May; 222
Li, Yang, Giachelli (bb0135) 2006 Apr 14; 98
Schlieper, Schurgers, Brandenburg, Reutelingsperger, Floege (bb0025) 2016 Jan; 31
Albright, Stabach, Cao, Kavanagh, Mullen, Braddock (bb0200) 2015; 6
Ho, Johnson, Kingsley (bb0195) 2000 Jul 14; 289
Cheng, Ramachandran, Behrmann, Shao, Mead, Smith (bb0185) 2015 Jul 03; 117
McCullough, Sandberg, Dumler, Yanez (bb0015) 2004 Mar-Apr; 17
Clevers (bb0150) 2006 Nov 3; 127
Gherghe, Duan, Gong, Rojas, Klauber-Demore, Majesky (bb0065) 2011 Jun; 25
Roman-Garcia, Carrillo-Lopez, Fernandez-Martin, Naves-Diaz, Ruiz-Torres, Cannata-Andia (bb0210) 2010 Jan; 46
Prosdocimo, Wyler, Romani, O'Neill, Dubyak (bb0085) 2010 Mar; 298
Brandenburg, Kramann, Koos, Kruger, Schurgers, Muhlenbruch (bb0060) 2013 Oct 10; 14
Hedgepeth, Conrad, Zhang, Huang, Lee, Klein (bb0140) 1997 May 1; 185
Cai, Yu, Jiang, Jiang, Pan, Qi (bb0115) 2005 Jul 15; 129
Goodman (bb0175) 2001 Oct 6; 358
Morena, Jaussent, Dupuy, Bargnoux, Kuster, Chenine (bb0215) 2015 Aug; 30
Fu, Yang, Fan, Chen, Wu, Li (bb0110) 2016 Feb; 85
MacDonald, Tamai, He (bb0155) 2009 Jul; 17
Shao (10.1016/j.yjmcc.2019.07.008_bb0030) 2005; 115
Fang (10.1016/j.yjmcc.2019.07.008_bb0045) 2014; 25
Brandenburg (10.1016/j.yjmcc.2019.07.008_bb0060) 2013; 14
Hruska (10.1016/j.yjmcc.2019.07.008_bb0120) 2007; 20
McCullough (10.1016/j.yjmcc.2019.07.008_bb0015) 2004; 17
Marchand (10.1016/j.yjmcc.2019.07.008_bb0190) 2011; 10
Cheng (10.1016/j.yjmcc.2019.07.008_bb0035) 2014; 63
Lomashvili (10.1016/j.yjmcc.2019.07.008_bb0170) 2005; 16
MacDonald (10.1016/j.yjmcc.2019.07.008_bb0155) 2009; 17
Cailotto (10.1016/j.yjmcc.2019.07.008_bb0165) 2010; 285
Johnson (10.1016/j.yjmcc.2019.07.008_bb0100) 2005; 25
Albright (10.1016/j.yjmcc.2019.07.008_bb0200) 2015; 6
London (10.1016/j.yjmcc.2019.07.008_bb0020) 2003; 18
Gherghe (10.1016/j.yjmcc.2019.07.008_bb0065) 2011; 25
Prosdocimo (10.1016/j.yjmcc.2019.07.008_bb0085) 2010; 298
Narisawa (10.1016/j.yjmcc.2019.07.008_bb0095) 2007; 22
Goodman (10.1016/j.yjmcc.2019.07.008_bb0010) 2000; 342
Qureshi (10.1016/j.yjmcc.2019.07.008_bb0050) 2015; 88
Cheng (10.1016/j.yjmcc.2019.07.008_bb0185) 2015; 117
Morena (10.1016/j.yjmcc.2019.07.008_bb0215) 2015; 30
Fu (10.1016/j.yjmcc.2019.07.008_bb0110) 2016; 85
Li (10.1016/j.yjmcc.2019.07.008_bb0135) 2006; 98
Roman-Garcia (10.1016/j.yjmcc.2019.07.008_bb0210) 2010; 46
Clevers (10.1016/j.yjmcc.2019.07.008_bb0150) 2006; 127
Foley (10.1016/j.yjmcc.2019.07.008_bb0005) 2005; 16
Neven (10.1016/j.yjmcc.2019.07.008_bb0040) 2010; 30
Hedgepeth (10.1016/j.yjmcc.2019.07.008_bb0140) 1997; 185
Ho (10.1016/j.yjmcc.2019.07.008_bb0195) 2000; 289
Kirkpantur (10.1016/j.yjmcc.2019.07.008_bb0055) 2015; 8
Cai (10.1016/j.yjmcc.2019.07.008_bb0115) 2005; 129
Fukuda (10.1016/j.yjmcc.2019.07.008_bb0145) 2016; 17
Luo (10.1016/j.yjmcc.2019.07.008_bb0160) 1997; 386
O'Neill (10.1016/j.yjmcc.2019.07.008_bb0205) 2010; 25
Wang (10.1016/j.yjmcc.2019.07.008_bb0090) 2004; 287
Schlieper (10.1016/j.yjmcc.2019.07.008_bb0025) 2016; 31
Zhu (10.1016/j.yjmcc.2019.07.008_bb0130) 2011; 6
Al-Aly (10.1016/j.yjmcc.2019.07.008_bb0180) 2007; 27
Goliasch (10.1016/j.yjmcc.2019.07.008_bb0070) 2012; 222
Sage (10.1016/j.yjmcc.2019.07.008_bb0080) 2010; 7
Goodman (10.1016/j.yjmcc.2019.07.008_bb0175) 2001; 358
Mani (10.1016/j.yjmcc.2019.07.008_bb0075) 2007; 315
Zhao (10.1016/j.yjmcc.2019.07.008_bb0105) 2012; 82
Giachelli (10.1016/j.yjmcc.2019.07.008_bb0125) 2009; 75
References_xml – volume: 16
  start-page: 489
  year: 2005 Feb
  end-page: 495
  ident: bb0005
  article-title: Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999
  publication-title: J. Am. Soc. Nephrol.
– volume: 222
  start-page: 251
  year: 2012 May
  end-page: 256
  ident: bb0070
  article-title: Premature myocardial infarction is associated with low serum levels of Wnt-1
  publication-title: Atherosclerosis.
– volume: 17
  start-page: 9
  year: 2016 May 20
  ident: bb0145
  article-title: Tubulin is a molecular target of the Wnt-activating chemical probe
  publication-title: BMC Biochem.
– volume: 63
  start-page: 4326
  year: 2014 Dec
  end-page: 4337
  ident: bb0035
  article-title: Targeted reduction of vascular Msx1 and Msx2 mitigates arteriosclerotic calcification and aortic stiffness in LDLR-deficient mice fed diabetogenic diets
  publication-title: Diabetes.
– volume: 25
  start-page: 187
  year: 2010 Jan
  end-page: 191
  ident: bb0205
  article-title: Plasma pyrophosphate and vascular calcification in chronic kidney disease
  publication-title: Nephrol. Dial. Transplant.
– volume: 25
  start-page: 1760
  year: 2014 Aug
  end-page: 1773
  ident: bb0045
  article-title: CKD-induced wingless/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder
  publication-title: J. Am. Soc. Nephrol.
– volume: 88
  start-page: 1356
  year: 2015 Dec
  end-page: 1364
  ident: bb0050
  article-title: Increased circulating sclerostin levels in end-stage renal disease predict biopsy-verified vascular medial calcification and coronary artery calcification
  publication-title: Kidney Int.
– volume: 358
  start-page: 1115
  year: 2001 Oct 6
  end-page: 1116
  ident: bb0175
  article-title: Vascular calcification in chronic renal failure
  publication-title: Lancet.
– volume: 287
  start-page: H2376
  year: 2004 Dec
  end-page: H2383
  ident: bb0090
  article-title: LDL receptor-related protein LRP6 regulates proliferation and survival through the Wnt cascade in vascular smooth muscle cells
  publication-title: Am. J. Physiol. Heart Circ. Physiol.
– volume: 22
  start-page: 1700
  year: 2007 Nov
  end-page: 1710
  ident: bb0095
  article-title: Novel inhibitors of alkaline phosphatase suppress vascular smooth muscle cell calcification
  publication-title: J. Bone Miner. Res.
– volume: 30
  start-page: 1741
  year: 2010 Sep
  end-page: 1750
  ident: bb0040
  article-title: Chondrocyte rather than osteoblast conversion of vascular cells underlies medial calcification in uremic rats
  publication-title: Arterioscler. Thromb. Vasc. Biol.
– volume: 30
  start-page: 1345
  year: 2015 Aug
  end-page: 1356
  ident: bb0215
  article-title: Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: potential partners in vascular calcifications
  publication-title: Nephrol. Dial. Transplant.
– volume: 315
  start-page: 1278
  year: 2007 Mar 2
  end-page: 1282
  ident: bb0075
  article-title: LRP6 mutation in a family with early coronary disease and metabolic risk factors
  publication-title: Science.
– volume: 46
  start-page: 121
  year: 2010 Jan
  end-page: 128
  ident: bb0210
  article-title: High phosphorus diet induces vascular calcification, a related decrease in bone mass and changes in the aortic gene expression
  publication-title: Bone.
– volume: 185
  start-page: 82
  year: 1997 May 1
  end-page: 91
  ident: bb0140
  article-title: Activation of the Wnt signaling pathway: a molecular mechanism for lithium action
  publication-title: Dev. Biol.
– volume: 17
  start-page: 205
  year: 2004 Mar-Apr
  end-page: 215
  ident: bb0015
  article-title: Determinants of coronary vascular calcification in patients with chronic kidney disease and end-stage renal disease: a systematic review
  publication-title: J Nephrol.
– volume: 16
  start-page: 2495
  year: 2005 Aug
  end-page: 2500
  ident: bb0170
  article-title: Reduced plasma pyrophosphate levels in hemodialysis patients
  publication-title: J. Am. Soc. Nephrol.
– volume: 298
  start-page: C702
  year: 2010 Mar
  end-page: C713
  ident: bb0085
  article-title: Regulation of vascular smooth muscle cell calcification by extracellular pyrophosphate homeostasis: synergistic modulation by cyclic AMP and hyperphosphatemia
  publication-title: Am. J. Phys. Cell Physiol.
– volume: 20
  start-page: 309
  year: 2007 Jul-Aug
  end-page: 315
  ident: bb0120
  article-title: Renal osteodystrophy, phosphate homeostasis, and vascular calcification
  publication-title: Semin. Dial.
– volume: 85
  start-page: 92
  year: 2016 Feb
  end-page: 100
  ident: bb0110
  article-title: Prediction of all-cause death in hemodialysis patients using elevated postdialysis pulse wave velocity
  publication-title: Clin. Nephrol.
– volume: 117
  start-page: 142
  year: 2015 Jul 03
  end-page: 156
  ident: bb0185
  article-title: Vascular smooth muscle LRP6 limits arteriosclerotic calcification in diabetic LDLR-/- mice by restraining noncanonical Wnt signals
  publication-title: Circ. Res.
– volume: 18
  start-page: 1731
  year: 2003 Sep
  end-page: 1740
  ident: bb0020
  article-title: Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality
  publication-title: Nephrol. Dial. Transplant.
– volume: 82
  start-page: 34
  year: 2012 Jul
  end-page: 44
  ident: bb0105
  article-title: Activation of nuclear factor-kappa B accelerates vascular calcification by inhibiting ankylosis protein homolog expression
  publication-title: Kidney Int.
– volume: 127
  start-page: 469
  year: 2006 Nov 3
  end-page: 480
  ident: bb0150
  article-title: Wnt/beta-catenin signaling in development and disease
  publication-title: Cell.
– volume: 285
  start-page: 10572
  year: 2010 Apr 2
  end-page: 10582
  ident: bb0165
  article-title: The inorganic pyrophosphate transporter ANK preserves the differentiated phenotype of articular chondrocyte
  publication-title: J. Biol. Chem.
– volume: 6
  year: 2015
  ident: bb0200
  article-title: ENPP1-Fc prevents mortality and vascular calcifications in rodent model of generalized arterial calcification of infancy
  publication-title: Nat. Commun.
– volume: 31
  start-page: 31
  year: 2016 Jan
  end-page: 39
  ident: bb0025
  article-title: Vascular calcification in chronic kidney disease: an update
  publication-title: Nephrol. Dial. Transplant.
– volume: 6
  year: 2011
  ident: bb0130
  article-title: The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells
  publication-title: PLoS One
– volume: 17
  start-page: 9
  year: 2009 Jul
  end-page: 26
  ident: bb0155
  article-title: Wnt/beta-catenin signaling: components, mechanisms, and diseases
  publication-title: Dev. Cell
– volume: 98
  start-page: 905
  year: 2006 Apr 14
  end-page: 912
  ident: bb0135
  article-title: Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification
  publication-title: Circ. Res.
– volume: 25
  start-page: 1836
  year: 2011 Jun
  end-page: 1843
  ident: bb0065
  article-title: Wnt1 is a proangiogenic molecule, enhances human endothelial progenitor function, and increases blood flow to ischemic limbs in a HGF-dependent manner
  publication-title: FASEB J.
– volume: 75
  start-page: 890
  year: 2009 May
  end-page: 897
  ident: bb0125
  article-title: The emerging role of phosphate in vascular calcification
  publication-title: Kidney Int.
– volume: 115
  start-page: 1210
  year: 2005 May
  end-page: 1220
  ident: bb0030
  article-title: Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals
  publication-title: J. Clin. Invest.
– volume: 8
  start-page: 737
  year: 2015 Dec
  end-page: 743
  ident: bb0055
  article-title: Independent association between serum sclerostin levels and carotid artery atherosclerosis in prevalent haemodialysis patients
  publication-title: Clin. Kidney J.
– volume: 342
  start-page: 1478
  year: 2000 May 18
  end-page: 1483
  ident: bb0010
  article-title: Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis
  publication-title: N. Engl. J. Med.
– volume: 27
  start-page: 2589
  year: 2007 Dec
  end-page: 2596
  ident: bb0180
  article-title: Aortic Msx2-Wnt calcification cascade is regulated by TNF-alpha-dependent signals in diabetic Ldlr−/− mice
  publication-title: Arterioscler. Thromb. Vasc. Biol.
– volume: 289
  start-page: 265
  year: 2000 Jul 14
  end-page: 270
  ident: bb0195
  article-title: Role of the mouse ank gene in control of tissue calcification and arthritis
  publication-title: Science.
– volume: 14
  start-page: 219
  year: 2013 Oct 10
  ident: bb0060
  article-title: Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study
  publication-title: BMC Nephrol.
– volume: 386
  start-page: 78
  year: 1997 Mar 6
  end-page: 81
  ident: bb0160
  article-title: Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein
  publication-title: Nature.
– volume: 129
  start-page: 125
  year: 2005 Jul 15
  end-page: 132
  ident: bb0115
  article-title: Adrenomedullin(27-52) inhibits vascular calcification in rats
  publication-title: Regul. Pept.
– volume: 10
  start-page: 220
  year: 2011 Apr
  end-page: 232
  ident: bb0190
  article-title: The Wnt/beta-catenin pathway is activated during advanced arterial aging in humans
  publication-title: Aging Cell
– volume: 7
  start-page: 528
  year: 2010 Sep
  end-page: 536
  ident: bb0080
  article-title: Regulatory mechanisms in vascular calcification
  publication-title: Nat. Rev. Cardiol.
– volume: 25
  start-page: 686
  year: 2005 Apr
  end-page: 691
  ident: bb0100
  article-title: Chondrogenesis mediated by PPi depletion promotes spontaneous aortic calcification in NPP1−/− mice
  publication-title: Arterioscler. Thromb. Vasc. Biol.
– volume: 82
  start-page: 34
  issue: 1
  year: 2012
  ident: 10.1016/j.yjmcc.2019.07.008_bb0105
  article-title: Activation of nuclear factor-kappa B accelerates vascular calcification by inhibiting ankylosis protein homolog expression
  publication-title: Kidney Int.
  doi: 10.1038/ki.2012.40
– volume: 88
  start-page: 1356
  issue: 6
  year: 2015
  ident: 10.1016/j.yjmcc.2019.07.008_bb0050
  article-title: Increased circulating sclerostin levels in end-stage renal disease predict biopsy-verified vascular medial calcification and coronary artery calcification
  publication-title: Kidney Int.
  doi: 10.1038/ki.2015.194
– volume: 85
  start-page: 92
  issue: 2
  year: 2016
  ident: 10.1016/j.yjmcc.2019.07.008_bb0110
  article-title: Prediction of all-cause death in hemodialysis patients using elevated postdialysis pulse wave velocity
  publication-title: Clin. Nephrol.
  doi: 10.5414/CN108547
– volume: 8
  start-page: 737
  issue: 6
  year: 2015
  ident: 10.1016/j.yjmcc.2019.07.008_bb0055
  article-title: Independent association between serum sclerostin levels and carotid artery atherosclerosis in prevalent haemodialysis patients
  publication-title: Clin. Kidney J.
  doi: 10.1093/ckj/sfv077
– volume: 98
  start-page: 905
  issue: 7
  year: 2006
  ident: 10.1016/j.yjmcc.2019.07.008_bb0135
  article-title: Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification
  publication-title: Circ. Res.
  doi: 10.1161/01.RES.0000216409.20863.e7
– volume: 6
  year: 2015
  ident: 10.1016/j.yjmcc.2019.07.008_bb0200
  article-title: ENPP1-Fc prevents mortality and vascular calcifications in rodent model of generalized arterial calcification of infancy
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms10006
– volume: 22
  start-page: 1700
  issue: 11
  year: 2007
  ident: 10.1016/j.yjmcc.2019.07.008_bb0095
  article-title: Novel inhibitors of alkaline phosphatase suppress vascular smooth muscle cell calcification
  publication-title: J. Bone Miner. Res.
  doi: 10.1359/jbmr.070714
– volume: 27
  start-page: 2589
  issue: 12
  year: 2007
  ident: 10.1016/j.yjmcc.2019.07.008_bb0180
  article-title: Aortic Msx2-Wnt calcification cascade is regulated by TNF-alpha-dependent signals in diabetic Ldlr−/− mice
  publication-title: Arterioscler. Thromb. Vasc. Biol.
  doi: 10.1161/ATVBAHA.107.153668
– volume: 16
  start-page: 489
  issue: 2
  year: 2005
  ident: 10.1016/j.yjmcc.2019.07.008_bb0005
  article-title: Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999
  publication-title: J. Am. Soc. Nephrol.
  doi: 10.1681/ASN.2004030203
– volume: 14
  start-page: 219
  year: 2013
  ident: 10.1016/j.yjmcc.2019.07.008_bb0060
  article-title: Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study
  publication-title: BMC Nephrol.
  doi: 10.1186/1471-2369-14-219
– volume: 17
  start-page: 9
  issue: 1
  year: 2016
  ident: 10.1016/j.yjmcc.2019.07.008_bb0145
  article-title: Tubulin is a molecular target of the Wnt-activating chemical probe
  publication-title: BMC Biochem.
  doi: 10.1186/s12858-016-0066-9
– volume: 25
  start-page: 686
  issue: 4
  year: 2005
  ident: 10.1016/j.yjmcc.2019.07.008_bb0100
  article-title: Chondrogenesis mediated by PPi depletion promotes spontaneous aortic calcification in NPP1−/− mice
  publication-title: Arterioscler. Thromb. Vasc. Biol.
  doi: 10.1161/01.ATV.0000154774.71187.f0
– volume: 285
  start-page: 10572
  issue: 14
  year: 2010
  ident: 10.1016/j.yjmcc.2019.07.008_bb0165
  article-title: The inorganic pyrophosphate transporter ANK preserves the differentiated phenotype of articular chondrocyte
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M109.050534
– volume: 25
  start-page: 1760
  issue: 8
  year: 2014
  ident: 10.1016/j.yjmcc.2019.07.008_bb0045
  article-title: CKD-induced wingless/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder
  publication-title: J. Am. Soc. Nephrol.
  doi: 10.1681/ASN.2013080818
– volume: 75
  start-page: 890
  issue: 9
  year: 2009
  ident: 10.1016/j.yjmcc.2019.07.008_bb0125
  article-title: The emerging role of phosphate in vascular calcification
  publication-title: Kidney Int.
  doi: 10.1038/ki.2008.644
– volume: 20
  start-page: 309
  issue: 4
  year: 2007
  ident: 10.1016/j.yjmcc.2019.07.008_bb0120
  article-title: Renal osteodystrophy, phosphate homeostasis, and vascular calcification
  publication-title: Semin. Dial.
  doi: 10.1111/j.1525-139X.2007.00300.x
– volume: 298
  start-page: C702
  issue: 3
  year: 2010
  ident: 10.1016/j.yjmcc.2019.07.008_bb0085
  article-title: Regulation of vascular smooth muscle cell calcification by extracellular pyrophosphate homeostasis: synergistic modulation by cyclic AMP and hyperphosphatemia
  publication-title: Am. J. Phys. Cell Physiol.
  doi: 10.1152/ajpcell.00419.2009
– volume: 10
  start-page: 220
  issue: 2
  year: 2011
  ident: 10.1016/j.yjmcc.2019.07.008_bb0190
  article-title: The Wnt/beta-catenin pathway is activated during advanced arterial aging in humans
  publication-title: Aging Cell
  doi: 10.1111/j.1474-9726.2010.00661.x
– volume: 31
  start-page: 31
  issue: 1
  year: 2016
  ident: 10.1016/j.yjmcc.2019.07.008_bb0025
  article-title: Vascular calcification in chronic kidney disease: an update
  publication-title: Nephrol. Dial. Transplant.
  doi: 10.1093/ndt/gfv111
– volume: 115
  start-page: 1210
  issue: 5
  year: 2005
  ident: 10.1016/j.yjmcc.2019.07.008_bb0030
  article-title: Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI24140
– volume: 315
  start-page: 1278
  issue: 5816
  year: 2007
  ident: 10.1016/j.yjmcc.2019.07.008_bb0075
  article-title: LRP6 mutation in a family with early coronary disease and metabolic risk factors
  publication-title: Science.
  doi: 10.1126/science.1136370
– volume: 63
  start-page: 4326
  issue: 12
  year: 2014
  ident: 10.1016/j.yjmcc.2019.07.008_bb0035
  article-title: Targeted reduction of vascular Msx1 and Msx2 mitigates arteriosclerotic calcification and aortic stiffness in LDLR-deficient mice fed diabetogenic diets
  publication-title: Diabetes.
  doi: 10.2337/db14-0326
– volume: 25
  start-page: 1836
  issue: 6
  year: 2011
  ident: 10.1016/j.yjmcc.2019.07.008_bb0065
  article-title: Wnt1 is a proangiogenic molecule, enhances human endothelial progenitor function, and increases blood flow to ischemic limbs in a HGF-dependent manner
  publication-title: FASEB J.
  doi: 10.1096/fj.10-172981
– volume: 6
  issue: 5
  year: 2011
  ident: 10.1016/j.yjmcc.2019.07.008_bb0130
  article-title: The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0019595
– volume: 30
  start-page: 1345
  issue: 8
  year: 2015
  ident: 10.1016/j.yjmcc.2019.07.008_bb0215
  article-title: Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: potential partners in vascular calcifications
  publication-title: Nephrol. Dial. Transplant.
  doi: 10.1093/ndt/gfv081
– volume: 46
  start-page: 121
  issue: 1
  year: 2010
  ident: 10.1016/j.yjmcc.2019.07.008_bb0210
  article-title: High phosphorus diet induces vascular calcification, a related decrease in bone mass and changes in the aortic gene expression
  publication-title: Bone.
  doi: 10.1016/j.bone.2009.09.006
– volume: 358
  start-page: 1115
  issue: 9288
  year: 2001
  ident: 10.1016/j.yjmcc.2019.07.008_bb0175
  article-title: Vascular calcification in chronic renal failure
  publication-title: Lancet.
  doi: 10.1016/S0140-6736(01)06299-7
– volume: 30
  start-page: 1741
  issue: 9
  year: 2010
  ident: 10.1016/j.yjmcc.2019.07.008_bb0040
  article-title: Chondrocyte rather than osteoblast conversion of vascular cells underlies medial calcification in uremic rats
  publication-title: Arterioscler. Thromb. Vasc. Biol.
  doi: 10.1161/ATVBAHA.110.204834
– volume: 289
  start-page: 265
  issue: 5477
  year: 2000
  ident: 10.1016/j.yjmcc.2019.07.008_bb0195
  article-title: Role of the mouse ank gene in control of tissue calcification and arthritis
  publication-title: Science.
  doi: 10.1126/science.289.5477.265
– volume: 18
  start-page: 1731
  issue: 9
  year: 2003
  ident: 10.1016/j.yjmcc.2019.07.008_bb0020
  article-title: Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality
  publication-title: Nephrol. Dial. Transplant.
  doi: 10.1093/ndt/gfg414
– volume: 222
  start-page: 251
  issue: 1
  year: 2012
  ident: 10.1016/j.yjmcc.2019.07.008_bb0070
  article-title: Premature myocardial infarction is associated with low serum levels of Wnt-1
  publication-title: Atherosclerosis.
  doi: 10.1016/j.atherosclerosis.2012.02.017
– volume: 17
  start-page: 9
  issue: 1
  year: 2009
  ident: 10.1016/j.yjmcc.2019.07.008_bb0155
  article-title: Wnt/beta-catenin signaling: components, mechanisms, and diseases
  publication-title: Dev. Cell
  doi: 10.1016/j.devcel.2009.06.016
– volume: 16
  start-page: 2495
  issue: 8
  year: 2005
  ident: 10.1016/j.yjmcc.2019.07.008_bb0170
  article-title: Reduced plasma pyrophosphate levels in hemodialysis patients
  publication-title: J. Am. Soc. Nephrol.
  doi: 10.1681/ASN.2004080694
– volume: 25
  start-page: 187
  issue: 1
  year: 2010
  ident: 10.1016/j.yjmcc.2019.07.008_bb0205
  article-title: Plasma pyrophosphate and vascular calcification in chronic kidney disease
  publication-title: Nephrol. Dial. Transplant.
  doi: 10.1093/ndt/gfp362
– volume: 287
  start-page: H2376
  issue: 6
  year: 2004
  ident: 10.1016/j.yjmcc.2019.07.008_bb0090
  article-title: LDL receptor-related protein LRP6 regulates proliferation and survival through the Wnt cascade in vascular smooth muscle cells
  publication-title: Am. J. Physiol. Heart Circ. Physiol.
  doi: 10.1152/ajpheart.01173.2003
– volume: 342
  start-page: 1478
  issue: 20
  year: 2000
  ident: 10.1016/j.yjmcc.2019.07.008_bb0010
  article-title: Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJM200005183422003
– volume: 7
  start-page: 528
  issue: 9
  year: 2010
  ident: 10.1016/j.yjmcc.2019.07.008_bb0080
  article-title: Regulatory mechanisms in vascular calcification
  publication-title: Nat. Rev. Cardiol.
  doi: 10.1038/nrcardio.2010.115
– volume: 117
  start-page: 142
  issue: 2
  year: 2015
  ident: 10.1016/j.yjmcc.2019.07.008_bb0185
  article-title: Vascular smooth muscle LRP6 limits arteriosclerotic calcification in diabetic LDLR-/- mice by restraining noncanonical Wnt signals
  publication-title: Circ. Res.
  doi: 10.1161/CIRCRESAHA.117.306712
– volume: 185
  start-page: 82
  issue: 1
  year: 1997
  ident: 10.1016/j.yjmcc.2019.07.008_bb0140
  article-title: Activation of the Wnt signaling pathway: a molecular mechanism for lithium action
  publication-title: Dev. Biol.
  doi: 10.1006/dbio.1997.8552
– volume: 386
  start-page: 78
  issue: 6620
  year: 1997
  ident: 10.1016/j.yjmcc.2019.07.008_bb0160
  article-title: Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein
  publication-title: Nature.
  doi: 10.1038/386078a0
– volume: 17
  start-page: 205
  issue: 2
  year: 2004
  ident: 10.1016/j.yjmcc.2019.07.008_bb0015
  article-title: Determinants of coronary vascular calcification in patients with chronic kidney disease and end-stage renal disease: a systematic review
  publication-title: J Nephrol.
– volume: 127
  start-page: 469
  issue: 3
  year: 2006
  ident: 10.1016/j.yjmcc.2019.07.008_bb0150
  article-title: Wnt/beta-catenin signaling in development and disease
  publication-title: Cell.
  doi: 10.1016/j.cell.2006.10.018
– volume: 129
  start-page: 125
  issue: 1–3
  year: 2005
  ident: 10.1016/j.yjmcc.2019.07.008_bb0115
  article-title: Adrenomedullin(27-52) inhibits vascular calcification in rats
  publication-title: Regul. Pept.
  doi: 10.1016/j.regpep.2005.02.017
SSID ssj0009433
Score 2.381828
Snippet Wnt signaling plays a critical role in vascular calcification (VC). Wnt factors induce different physiological and pathological effects on cardiovascular...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 10
SubjectTerms ANKH
Chronic kidney disease
Vascular calcification
Vascular smooth muscle cells
Wnt1
Title Wnt1 inhibits vascular smooth muscle cell calcification by promoting ANKH expression
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0022282818311970
https://dx.doi.org/10.1016/j.yjmcc.2019.07.008
https://www.ncbi.nlm.nih.gov/pubmed/31356809
https://www.proquest.com/docview/2267012737
Volume 135
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS8MwEA9DQXwRv51fRPDR6tKkyfo4RJmO7UEUfQtNm2qH64brQF_8271L24ngB_hUWnK0vUvuLrnf3RFyzGCF2dQYD4yJ9URgQ8-ApfeEBeMZWdUyMSY49weyeyeuH4KHBjmvc2EQVlnp_lKnO21dPTmruHk2yTLM8cXTC6xmxDEWhvt2IRTO8tP3T5hHKMp28ohax9F15SGH8XobjmKsY8hCV8ETe0x-b51-8j6dFbpcJSuV-0g75ReukYbN18lSvwqQb5Db-7xgNMufMpMVU1rjTOl0NAaR0NFsCmQUT-spCMfh8ZxoqHmjkxKZlz_SzqDXpfa1wsjmm-Tu8uL2vOtVjRO8WChVeNJEwoZMMMUMixMple9HPuMJ1kdTNjApLOM2bIRSbiKTuObeAYwMLIsiaVt8iyzk49zuEAreTcAsl0Ylvkh4GvlJCk-kSZPYj9u8SfyaYTquqopjc4tnXcPHhtpxWSOXdQuj3e0mOZkTTcqiGr8PF7UkdJ0vChpOg9L_nUzOyb5Mqb8Jj2pxa1hsKJMot-PZVIOvqjBWz1WTbJfzYP4DnPFAtlvh7n9fu0eW8a5ECu6TheJlZg_A4ynMoZvSh2Sxc9XrDvDau7nvfQBAqgC9
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKkYAL4lkWChgJboTGj9ibQw8VUG3Z7p62ojcTJw6kYrMrkhXshT_VP9gZx1mEBEVC6tXx5DEez4wz38wQ8pLBDnOltREYExfJxKWRBUsfSQfGM3M6tjkmOE-manQiP5wmp1vkvM-FQVhl0P2dTvfaOozsBW7uLasKc3zx7wVWMxIYC4sDsnLs1t_h3NbsH72DRX7F-eH72dtRFFoLRLnUuo2UzaRLmWSaWZYXSmnOM85EgRXEtEtsCYI-hKNCKWxmC9_-OoGZiWNZplws4L7XyHUJ6gLbJrz5-QtXksqufz3C5PH1-lJHHlS2PpvnWDiRpb5kKDa1_LM5_Ju7683e4R1yO_ir9KBjyV2y5ep75MYkROTvk9nHumW0qr9Utmob2gNbaTNfgAzQ-aoBMorhAQrS4AGAXhaoXdNlBwWsP9OD6XhE3Y8Ayq0fkJMrYedDsl0vaveIUHCnEuaEsrrgshBlxosSRpQti5znQzEgvGeYyUMZc-ym8dX0eLUz47lskMsmxvD6cEBeb4iWXRWPy6fLfiVMn6AKKtWAlbmcTG3IfpPhfxO-6JfbwO7GNclqt1g1BpxjjeAAoQdkp5ODzQcIJhI1jNPH__vY5-TmaDY5NsdH0_ETcguvdDDFXbLdflu5p-ButfaZF29KPl31froAgJM5cA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Wnt1+inhibits+vascular+smooth+muscle+cell+calcification+by+promoting+ANKH+expression&rft.jtitle=Journal+of+molecular+and+cellular+cardiology&rft.au=Chen%2C+Beidong&rft.au=Zhao%2C+Yang&rft.au=Han%2C+Duanyang&rft.au=Zhao%2C+Ban&rft.date=2019-10-01&rft.pub=Elsevier+Ltd&rft.issn=0022-2828&rft.volume=135&rft.spage=10&rft.epage=21&rft_id=info:doi/10.1016%2Fj.yjmcc.2019.07.008&rft.externalDocID=S0022282818311970
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-2828&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-2828&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-2828&client=summon